Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"Neuroendocrine Cancer"”.
-
Detection of Calcitonin Precursors and the Regulation of their Biosynthesis in Human Neuroendocrine Cancer Cells
… pathway have been identified in lung-derived neuroendocrine cancer cells, the biosynthetic regulation of CT in thyroid-derived neuroendocrine tumours remains poorly defined. Consequently, the mechanisms governing CT maturation, storage, and secretion in MTC are incompletely understood. This …
-
Functional Genomic Screens to Elucidate Alternative Splicing and Circular RNA Biogenesis Regulators Driving Neuroendocrine Cancer Progression
Cancer progression remains a major clinical challenge, with treatment resistance and recurrence serving as continuing hurdles to overcome. Neuroendocrine (NE) cancers, such as small cell lung carcinomas (SCLC), represent a highly lethal subset of tumors, in which progression can result in rapid …
-
Preferences for the Role in Making Treatment Decisions: A Comparison between Patients and Patient Advocates in the Neuroendocrine Cancer Population
… adult patients and patient advocates with a rare cancer, neuroendocrine (NETs), wish to play in their care, and 2) to test the hypothesized relationship with ehealth literacy, trust in physician, information seeking behaviours and sociodemographic variables within and across both groups (patients …
-
Upregulation Of Somatostatin Receptor 2 In Neuroendocrine Tumors Using Histone Deacetylase Inhibitors
Neuroendocrine cancer is complex disease of the diffuse neuroendocrine system. Neuroendocrine tumors (NETs) can arise throughout the body, including the lungs and pancreas. These tumors are phenotypically and genetically heterogeneous, making accurate diagnoses difficult with current imaging …
-
Analysis of ASCL1 in Neuroendocrine Lung Cancer
Small cell lung cancer (SCLC) is an understudied tumor subset with aggressive neuroendocrine carcinoma features. Previous studies have determined that the basic helix-loop-helix (bHLH) transcription factor achaete-scute homolog 1 (ASCL1) is essential for the survival and progression of many …
-
Early Drivers of Lineage Plasticity in Neuroendocrine Prostate Cancer Identify Key Molecular Pathways and Potential Therapeutic Targets
<p>Neuroendocrine prostate cancer (NEPC) is a highly aggressive and difficult totreat advanced prostate cancer that often develops when the disease becomes resistant to long-term hormone (androgen) therapy. This transition occurs because cancer cells can significantly alter their identity, …
-
Investigating Drivers of Chemoresistance in Small Cell Lung Cancer
Small cell lung cancer (SCLC) is an aggressive neuroendocrine cancer characterized by initial chemosensitivity followed by rapid emergence of chemoresistant disease. To study the role of MYC family members in SCLC chemoresistance we utilized genetically engineered mouse models of SCLC and found …
-
Functional assessment of gastroenteropancreatic neuroendocrine tumor’s (GEP- NET) sensitivity to bio- and chemotherapeutic drugs and the role of survivin and aurora kinase B expression in GEP-NET disease
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are poorly understood lesions that encompass a broad category of neoplasms derived from neuroendocrine cells of the gastrointestinal mucosa and the pancreas. The lesions are grouped based on the acceptance that they have a common cell lineage …
-
Investigating the Novel Oncogenic Function of SAPCD2 in Pediatric Neuroblastoma
… in infants and children. It is an aggressive neuroendocrine cancer that circumvents the normal differentiation process of sympathetic neuronal precursors into diverse cell types of the peripheral nervous system. SAPCD2 is a newly identified cell cycle-associated gene involved in mitotic …
-
Investigating microRNA-375 as a Tissue and Circulating Marker for Neuroendocrine Cells and Neoplasms
Neuroendocrine neoplasia is an enigmatic disease that is currently without reliable diagnostic markers. Normal neuroendocrine cells are difficult to recognize upon routine H&E staining, requiring several IHC markers to confirm their cell-type. A lack of a single, specific marker has led to …
-
RET Kinase is transcriptionally regulated by ASCL1 in Neuroendocrine Prostate Cancer and Small Cell Lung Cancer
… androgen deprivation therapies often causes neuroendocrine prostate cancer (NEPC), an aggressive disease variant, in castration-resistant prostate cancer patients. Due to low survival outcomes and limited therapeutic interventions for patients, it is imperative to study the molecular basis of …
-
ClC-channels and Etoposide Resistance in the Neuorendocrine Tumour Cell Line LCC-18
… a major challenge in the treatment of metastatic neuroendocrine cancer. Chemotherapeutic regimes for these tumours employ weak- base drugs including, for instance, etoposide. Especially for this medication, a mechanism of resistance was suggested that linked increased acidification of …
-
In vitro evaluation of the efficacy of selected medicinal plant extracts against multidrug resistant cancer cells
Cancer is ranked as one of the leading causes of death globally, and a significant number of these diagnosed malignancies are found in lung tissue. Small cell lung cancer (SCLC) is a high grade neuroendocrine cancer, which is responsible for high mortality rates worldwide. The failure of …
-
The Roles of the Polyspecific Organic Cation Transporters in the Disposition of meta-Iodobenzylguanidine and Implications for Toxicities and Drug Interactions
… diagnostic agent and a targeted radiotherapy for neuroendocrine cancers. 131I-mIBG enters the cancer cells through the human norepinephrine transporter (hNET) where radioactive decay of 131I causes DNA damage, cell death, and tumor necrosis. Despite its selective accumulation in neuroendocrine …
-
Prognose von extrapulmonalen neuroendokrinen G3-Karzinomen des Urogenitaltrakts
Introduction: Extrapulmonary neuroendocrine G3 carcinomas of the urogenital tract (GU-NEC) are rare, aggressive malignancies with poor prognosis. Their treatment is largely guided by institutional expertise and therapeutic approaches adapted from small cell lung cancer. Methods: A retrospective …